Literature DB >> 16000285

Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies.

Michael J Reinhardt1, Holger Strunk, Thomas Gerhardt, Roland Roedel, Ursula Jaeger, Jan Bucerius, Tilman Sauerbruch, Hans-Juergen Biersack, Franz L Dumoulin.   

Abstract

UNLABELLED: Detection of cholangiocarcinoma in extrahepatic bile duct strictures is a continuing challenge in clinical practice because brush cytology taken at endoscopic retrograde cholangiography has an average sensitivity of 50%. The aim of this study was to evaluate the effectiveness of dual-modality PET/CT using (18)F-FDG for noninvasive differentiation of extrahepatic bile duct strictures.
METHODS: Twenty-two PET/CT studies were performed on 20 patients (10 women, 10 men; mean age +/- SD, 63 +/- 14 y) with extrahepatic bile duct strictures on endoscopic retrograde cholangiography. PET imaging was started 101 +/- 22 min after injection of 369 +/- 48 MBq of 18F-FDG. Blood glucose was 100 +/- 20 mg/dL. PET images were reconstructed iteratively with attenuation correction based on a rescaling of the CT image. CT was performed within 1 min before the PET study, with the patient in the same position. CT was used to place a volume of interest 5 cm in diameter at the liver hilus for quantitative evaluation of PET images by means of standardized uptake values (SUVs).
RESULTS: Final diagnosis was histologically proven cholangiocarcinoma in 14 cases and benign causes of strictures in 8 cases without evidence of malignancy during a follow-up of 18 +/- 3 mo. All patients with cholangiocarcinoma presented with focal increased uptake in the liver hilus with an SUV of 6.8 +/- 3.3 (range, 3.9-15.8), compared with 2.9 +/- 0.3 (range, 2.5-3.3) in patients with benign causes of strictures (P = 0.003). There was a clear cutoff SUV of 3.6 for detection of malignancy in the liver hilus.
CONCLUSION: 18F-FDG PET/CT provided high accuracy for noninvasive detection of perihilar cholangiocarcinoma in extrahepatic bile duct strictures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000285

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Authors:  Amir A Rahnemai-Azar; Pallavi Pandey; Ihab Kamel; Timothy M Pawlik
Journal:  Hepat Oncol       Date:  2017-01-20

2.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

3.  FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.

Authors:  Anthony T Ruys; Roel J Bennink; Henderik L van Westreenen; Marc R Engelbrecht; Olivier R Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

4.  Management and outcome in patients with Klatskin-mimicking lesions of the biliary tree.

Authors:  Dirk Uhlmann; Marcus Wiedmann; Frank Schmidt; Regine Kluge; Andrea Tannapfel; Frieder Berr; Johann Hauss; Helmut Witzigmann
Journal:  J Gastrointest Surg       Date:  2006 Sep-Oct       Impact factor: 3.452

5.  The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma.

Authors:  Yeongjoo Lee; Ie Ryung Yoo; Sun Ha Boo; Hyoungwoo Kim; Hye Lim Park; Joo Hyun O
Journal:  Nucl Med Mol Imaging       Date:  2016-08-06

6.  Therapeutical concepts and results for Klatskin tumors.

Authors:  Helmut Witzigmann; Marcus Wiedmann; Christian Wittekind; Joachim Mössner; Johann Hauss
Journal:  Dtsch Arztebl Int       Date:  2008-02-29       Impact factor: 5.594

7.  Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.

Authors:  Hiroyoshi Furukawa; Hiroki Ikuma; Koiku Asakura-Yokoe; Katsuhiko Uesaka
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

Review 8.  Cholangiocarcinoma: a compact review of the literature.

Authors:  Yucel Ustundag; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

Review 9.  Diagnostic approaches for cholangiocarcinoma.

Authors:  Andreas Weber; Roland-M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

10.  Diagnosis of cholangiocarcinoma.

Authors:  B E Van Beers
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.